Peter Jirak
Impact in
-
- Atrial Fibrillation Management and Outcomes
- Heart Failure Treatment and Management
- Acute Myocardial Infarction Research
- Cardiac Valve Diseases and Treatments
- Internal Medicine top 5%
Papers in
-
- Heart Failure Treatment and Management 9
- Cardiac Valve Diseases and Treatments 7
- Acute Myocardial Infarction Research 4
- Cardiac pacing and defibrillation studies 2
-
- COVID-19 Clinical Research Studies 11
- Co-authors
- Uta Charlotte Hoppe (41 shared papers)Bernhard Wernly (23 shared papers)Michael Lichtenauer (20 shared papers)Vera Paar (23 shared papers)Michael Lichtenauer (24 shared papers)Lukas Jaroslaw Motloch (28 shared papers)Christian Jung (18 shared papers)Moritz Mirna (18 shared papers)
In The Last Decade
Peter Jirak
59 papers receiving 1.1k citations
Peter Jirak's Hit Papers
Peers
Comparison fields: 5 of 90
- Cardiology and Cardiovascular Medicine 544
- Internal Medicine 53
- Genetics 94
- Hematology 113
- Infectious Diseases 83
Countries citing papers authored by Peter Jirak
This map shows the geographic impact of Peter Jirak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Jirak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Jirak more than expected).
Fields of papers citing papers by Peter Jirak
This network shows the impact of papers produced by Peter Jirak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Jirak. The network helps show where Peter Jirak may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Jirak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study Hit paper breakdown → | 2022 | 249 |
| 2 | 2020 | 82 | |
| 3 | 2020 | 68 | |
| 4 | 2021 | 61 | |
| 5 | 2017 | 56 | |
| 6 | 2020 | 51 | |
| 7 | 2019 | 46 | |
| 8 | 2020 | 37 | |
| 9 | 2022 | 35 | |
| 10 | 2019 | 33 | |
| 11 | 2020 | 32 | |
| 12 | 2024 | 31 | |
| 13 | 2016 | 30 | |
| 14 | 2020 | 28 | |
| 15 | 2020 | 25 | |
| 16 | 2017 | 22 | |
| 17 | 2018 | 19 | |
| 18 | 2022 | 15 | |
| 19 | 2019 | 14 | |
| 20 | 2022 | 14 |
About Peter Jirak
Peter Jirak is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases, Rheumatology, Physiology and Nephrology, having authored 62 papers that have together received 1.2k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (11 papers), Heart Failure Treatment and Management (9 papers), Spaceflight effects on biology (8 papers), Cardiac Valve Diseases and Treatments (7 papers), GDF15 and Related Biomarkers (6 papers), Acute Myocardial Infarction Research (4 papers), Pulmonary Hypertension Research and Treatments (2 papers) and Cardiac pacing and defibrillation studies (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (544 citations), Internal Medicine (53 citations), Genetics (94 citations), Hematology (113 citations) and Infectious Diseases (83 citations). Peter Jirak has collaborated with scholars based in Austria, Germany and Russia. Frequent co-authors include Uta Charlotte Hoppe, Bernhard Wernly, Michael Lichtenauer, Vera Paar, Michael Lichtenauer, Lukas Jaroslaw Motloch, Christian Jung, Moritz Mirna, Daniel Kretzschmar and Paul Christian Schulze. Their work appears in journals such as Journal of Clinical Medicine, European Heart Journal, Frontiers in Cardiovascular Medicine, Applied Sciences and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.